Pharmaceutical Stock Bounces Off Record Lows

Core Viewpoint - Kenvue Inc (NYSE:KVUE) stock has increased by 3.9% to $17.62, recovering some losses from the previous day due to controversy surrounding acetaminophen use during pregnancy and its alleged link to autism, which has been criticized by medical professionals for lacking scientific evidence [1] Stock Performance - KVUE is rebounding from a record low of $16.89 but still needs to recover from a 7.5% bear gap and is trading below the 20-day moving average, with a year-over-year deficit of 23.3% [2] Options Activity - The options market shows a more pessimistic sentiment than usual, with KVUE's 50-day put/call volume ratio ranking higher than 90% of annual readings across major exchanges [3] - Today's options activity includes 112,000 calls and 60,000 puts, which is six times the typical volume, with the most popular contracts being the November 19 and 23 calls, alongside new positions at the weekly 10/3 17.50-strike put [4]